We are delighted to welcome you to this new event at Lille in France, with the 2026 International Congress on Infectious and Inflammatory Diseases. This congress will be the opportunity to have an update on most recent research on infectious and inflammatory diseases to combat resistance to treatments and complications, as well as an overview of high scientific impact projects carried out as part of the CPER Resist-omics program (2021-2027), a major project that we have been working on for the past five years at the intersection of inflammatory and infectious diseases.

See you soon !

Dr Nathalie Mielcarek and Pr David Launay

The 2026 International Congress on Infectious and Inflammatory Diseases is organised with the support of the CPER Resit-omics project, a project funded under the 2021-2027 Contrat Plan Etat-Région (CPER) with the support from the Hauts-de-France Region, the Lille European Metropolis (MEL), the French State, and the European Fund for Regional Economic Development (FEDER).

Since 2021, CPER Resist-omics, led by Nathalie Mielcarek, Benoit Deprez and David Launay has brought together research units and centers such as INFINITE (Lille Institute for Translational Research in Inflammation U1286 Inserm), Drugs & Molecules For Living Systems (U1177) and Center for Infection and Immunity of Lille, affiliated to University of Lille, Lille University Hospital, Institut Pasteur de Lille, CNRS and INSERM, with the objective to promote collaborations and synergy in the fields of infection and inflammation.

This project lays the foundation for the establishment of the interdisciplinary federative Institute in Inflammatory and Infectious diseases of Lille (I4Lille) in 2026.